';
Policy Areas

The Office of Developmental Programs (ODP) has shared the announcement Additional Guidance for the End of Appendix K Flexibilities in the Consolidated, Community Living, Person/Family Directed Support (P/FDS) and Adult Autism Waivers. The purpose of the communication is to provide additional guidance on which Appendix K waiver flexibilities have been added to the approved intellectual disability/autism waivers (ID/A), which are the Consolidated, Community Living, and P/FDS Waivers, and the Adult Autism Waiver (AAW), as well as which Appendix K flexibilities will be ending November 11, 2023. You can view a quick guide for ID/A Waivers and a quick guide for the Adult Autism Waiver.

Please review all documents for additional information and details.

The Office of Developmental Programs (ODP) has shared that registration is open for two upcoming sessions focused on ODP expectations of Residential Provider Executive Leadership (Chief Executive Officers, Chief Operating Officers, and Executive Directors of Residential Services) in the implementation of the Residential ISP Staffing approach. Please review the announcement for registration information and additional details.

Tuesday, November 28, 2023
1:00 pm – 2:00 pm EST; 12:00 pm – 1:00 pm CST;
11:00 am – 12:00 pm MST; 10:00 am – 11:00 am PST

Chani Traube, MD, FAAP, FCCM
Speaker/Panelist Bio:
Dr. Chani Traube is Professor of Pediatrics in the Division of Pediatric Critical Care, and Director of Clinical Research Mentoring for the Department of Pediatrics at Weill Cornell Medicine. She is also Chair of the National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). Dr. Traube is a clinical researcher with expertise in pediatrics, pediatric critical illness, delirium, sedation, and PICU outcomes. She is the Principal Investigator for several NIH-funded multi-site studies investigating the epidemiology of delirium, pharmacokinetics of sedatives, and long-term cognitive outcomes in critically ill children.

Objectives: At the end of this session, the learner will:

  • Define pediatric delirium and its associated morbidity;
  • Describe the prevalence and morbidity of delirium in seriously ill children;
  • Recognize that delirium occurs frequently in children with Acquired Brain Injury during inpatient rehabilitation; and
  • Verify that widespread screening for pediatric delirium is feasible.

Audience: This webinar is intended for all members of the rehabilitation team, including medical staff, nurses, physical therapists, occupational therapists, speech language pathologists, licensed psychologists, mental health professionals, and other interested professionals.

Level: Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are provided for this course.

Registration: *Please note that this event is hosted on a different platform; no pre-registration is required. 
Join Zoom Meeting
Meeting ID: 975 8167 5193

One tap mobile
+16469313860,,97581675193# US
+16468769923,,97581675193# US (New York)

Dial by your location
• +1 646 931 3860 US
• +1 646 876 9923 US (New York)
• +1 312 626 6799 US (Chicago)
• +1 301 715 8592 US (Washington DC)
• +1 305 224 1968 US
• +1 309 205 3325 US
• +1 689 278 1000 US
• +1 719 359 4580 US
• +1 253 205 0468 US
• +1 253 215 8782 US (Tacoma)
• +1 346 248 7799 US (Houston)
• +1 360 209 5623 US
• +1 386 347 5053 US
• +1 507 473 4847 US
• +1 564 217 2000 US
• +1 669 444 9171 US
• +1 669 900 6833 US (San Jose)

The Office of Developmental Programs (ODP) has shared important information about eye drops from the U.S. Food and Drug Administration. Eye drops from the 26 products listed here in the FDA MedWatch warning should not be used. CVS, Rite Aid, and Target are removing the products from their store shelves and websites. Products branded as Leader, Rugby, and Velocity may still be available to purchase in stores and online and should not be purchased.

The Office of Developmental Programs (ODP) has shared the updated communication, ODPANN 23-076: Annual Submittal of Financial Statements. The purpose of this announcement is to remind residential providers and support coordination organizations (SCO) that they are required to provide a *PDF of their fiscal year-end financial statements with the approval of the most recent waiver amendments. The waiver amendments were approved October 18, 2023.

Please review the announcement for additional information. Note that updates are marked in red.